A new opportunity for thalidomide? Further randomised controlled trial are necessary

Eur J Clin Pharmacol. 2004 Oct;60(8):607-8. doi: 10.1007/s00228-004-0819-z. Epub 2004 Sep 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Child
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Inflammatory Bowel Diseases / drug therapy
  • Randomized Controlled Trials as Topic
  • Thalidomide / adverse effects
  • Thalidomide / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Thalidomide